المؤلفون: Massaro F., Pavone V., Stefani P. M., Botto B., Pulsoni A., Patti C., Cantonetti M., Visentin A., Scalzulli P. R., Rossi A., Galimberti S., Cimminiello M., Gini G., Musso M., Sorio M., Arcari A., Zilioli V. R., Luppi M., Mannina D., Fabbri A., Pietrantuono G., Annibali O., Tafuri A., Prete E., Mule A., Barbolini E., Marcheselli L., Luminari S., Merli F.

المساهمون: Massaro, F., Pavone, V., Stefani, P. M., Botto, B., Pulsoni, A., Patti, C., Cantonetti, M., Visentin, A., Scalzulli, P. R., Rossi, A., Galimberti, S., Cimminiello, M., Gini, G., Musso, M., Sorio, M., Arcari, A., Zilioli, V. R., Luppi, M., Mannina, D., Fabbri, A., Pietrantuono, G., Annibali, O., Tafuri, A., Prete, E., Mule, A., Barbolini, E., Marcheselli, L., Luminari, S., Merli, F.

مصطلحات موضوعية: AETHERA trial, autologous stem cell transplantation, brentuximab vedotin, hodgkin lymphoma, Adolescent, Adult, Aged, Antineoplastic Agents, Immunological, Combined Modality Therapy, Female, Follow-Up Studie, Hematopoietic Stem Cell Transplantation, Hodgkin Disease, Human, Male, Middle Aged, Prognosi, Retrospective Studie, Survival Rate, Young Adult

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34694649; info:eu-repo/semantics/altIdentifier/wos/WOS:000713467600001; volume:40; issue:1; firstpage:31; lastpage:39; numberofpages:9; journal:HEMATOLOGICAL ONCOLOGY; http://hdl.handle.net/11380/1269519Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85118336432

الإتاحة: https://doi.org/10.1002/hon.2939Test
http://hdl.handle.net/11380/1269519Test

المؤلفون: Castagnetti F, Gugliotta G., Breccia M., Stagno F., Iurlo A., Albano F., Abruzzese E., Martino B., Levato L., Intermesoli T., Pregno P., Rossi G., Gherlinzoni F., Leoni P., Cavazzini F., Venturi C., Soverini S., Testoni N., Alimena G., Cavo M., Martinelli G., Pane F., Saglio G., Rosti G., Baccarani M., on behalf of the GIMEMA CML Working Party (Lucarelli G., Polimeno G., Ladetto M., Pini M., Rupoli S., Scortechini A. R., Galieni P., Bigazzi C., Cantore N., Palmieri F., Specchia G., Russo Rossi., Rambaldi A., Ferrari M. L., Palandri F., Luatti S., Iacobucci I., Bochicchio M. T., Apolinari M., Fogli M., Cervello I., Capucci A., Giuliani G., Malpignano A., Girasoli M., Angelucci E., Usala E., De Biasi E., Tagariello G., Sartori R., Di Raimondo F., Vigneri P., Molica S., Lentini M., Lanza F., Viganò C., Grasso M., Rapezzi D., Cuneo A., Ciccone M., Bosi A., Gozzini A., Gobbi M., Pierri I., Chianese R., De Blasio A., Ciccone F., Capochiani E., Pelosini M., Musolino C., Russo S., Cortelezzi A., Luppi M., Marasca R., Pogliani E. M., Gambacorti-Passerini C., Luciano L., Izzo B., Ferrara F., Annunziata M., Mettivier V., Sessa U., Latte G., Noli D., Rege-Cambrin G., Fava C., Semenzato G., Binotto G., Fabbiano F., Turri D., Siragusa S., Caracciolo C., Musso M., Porretto F., Cazzola M., Orlandi E., Falini B., Falzetti F., Visani G., Isidori., Di Bartolomeo P., Di Lorenzo R., Vallisa D., Trabacchi., Pizzuti M., Zuffa E., Salvucci M., Ronco F., lelo D., Merli F., Avanzini P., Tosi P., Merli A., Sica S., Sorà F., Latagliata R., De Fabritiis P., Trawiska M., Amadori S., Cantonetti M., Majolino I., Pacilli L., Ronci B., Cedrone M., Mengarelli A., Romano A., Tafuri A., Montefusco., Iuliano F., Infusino S., Dore F., Fozza C., Bocchia M., Defina M., Liberati AM., Luzi D., Boccadoro M., Ferrero D., Vitolo U., Nicolosi M., Gottardi M., Calistri E., Fanin R., Tiribelli M., Pizzolo G., Bonifacio M., Rodeghiero F., Di Bona E. )

المساهمون: Castagnetti, F, Gugliotta, G., Breccia, M., Stagno, F., Iurlo, A., Albano, F., Abruzzese, E., Martino, B., Levato, L., Intermesoli, T., Pregno, P., Rossi, G., Gherlinzoni, F., Leoni, P., Cavazzini, F., Venturi, C., Soverini, S., Testoni, N., Alimena, G., Cavo, M., Martinelli, G., Pane, F., Saglio, G., Rosti, G., Baccarani, M., on behalf of the GIMEMA CML Working Party (Lucarelli, G., Polimeno, G., Ladetto, M., Pini, M., Rupoli, S., Scortechini, A. R., Galieni, P., Bigazzi, C., Cantore, N., Palmieri, F., Specchia, G., Russo, Rossi., Rambaldi, A., Ferrari, M. L., Palandri, F., Luatti, S., Iacobucci, I., Bochicchio, M. T., Apolinari, M., Fogli, M., Cervello, I., Capucci, A., Giuliani, G., Malpignano, A., Girasoli, M., Angelucci, E., Usala, E., De Biasi, E., Tagariello, G., Sartori, R., Di Raimondo, F., Vigneri, P., Molica, S., Lentini, M., Lanza, F., Viganò, C., Grasso, M., Rapezzi, D., Cuneo, A., Ciccone, M., Bosi, A., Gozzini, A., Gobbi, M., Pierri, I., Chianese, R., De Blasio, A., Ciccone, F., Capochiani, E., Pelosini, M., Musolino, C., Russo, S., Cortelezzi, A., Luppi, M., Marasca, R., Pogliani, E. M., Gambacorti-Passerini, C., Luciano, L., Izzo, B., Ferrara, F., Annunziata, M., Mettivier, V., Sessa, U., Latte, G., Noli, D., Rege-Cambrin, G., Fava, C., Semenzato, G., Binotto, G., Fabbiano, F., Turri, D., Siragusa, S., Caracciolo, C., Musso, M., Porretto, F., Cazzola, M.

مصطلحات موضوعية: Adolescent, Adult, Aged, 80 and over, Antineoplastic Agent, Antineoplastic Combined Chemotherapy Protocol, Female, Follow-Up Studie, Fusion Proteins, bcr-abl, Human, Imatinib Mesylate, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Male, Middle Aged, Prognosi, Protein Kinase Inhibitor, Retreatment, Time Factor, Treatment Outcome, Young Adult, Hematology, Cancer Research, Anesthesiology and Pain Medicine

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26088952; info:eu-repo/semantics/altIdentifier/wos/WOS:000360937800003; volume:29; issue:9; firstpage:1823; lastpage:1831; numberofpages:9; journal:LEUKEMIA; http://hdl.handle.net/11392/2354365Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84940757131; https://www.nature.com/articles/leu2015152Test

الإتاحة: https://doi.org/10.1038/leu.2015.152Test
http://hdl.handle.net/11392/2354365Test
https://www.nature.com/articles/leu2015152Test

المؤلفون: Marchesi F., Pimpinelli F., Di Domenico E. G., Renzi D., Gallo M. T., Regazzo G., Rizzo M. G., Gumenyuk S., Toma L., Marino M., Cordone I., Cantonetti M., Liberati A. M., Montanaro M., Ceribelli A., Prignano G., Palombi F., Romano A., Papa E., Pisani F., Spadea A., Arcese W., Ensoli F., Mengarelli A.

المساهمون: Marchesi, F, Pimpinelli, F, Di Domenico, Eg, Renzi, D, Gallo, Mt, Regazzo, G, Rizzo, Mg, Gumenyuk, S, Toma, L, Marino, M, Cordone, I, Cantonetti, M, Liberati, Am, Montanaro, M, Ceribelli, A, Prignano, G, Palombi, F, Romano, A, Papa, E, Pisani, F, Spadea, A, Arcese, W, Ensoli, F, Mengarelli, A

مصطلحات موضوعية: CMV infection, autologous stem cell transplant, gram negative bacteria, gram positive bacteria, invasive fungal disease, lymphoma, multiple myeloma, skin commensal, Adolescent, Adult, Aged, Cohort Studie, Cytomegalovirus Infection, Female, Hematopoietic Stem Cell Transplantation, Human, Invasive Fungal Infection, Lymphoproliferative Disorder, Male, Middle Aged, Multivariate Analysi, Opportunistic Infection, Risk Factor, Transplantation, Autologou, Young Adult, Settore MED/15 - MALATTIE DEL SANGUE

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30893777; info:eu-repo/semantics/altIdentifier/wos/WOS:000464326900007; volume:20; issue:6; firstpage:1373; journal:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; http://hdl.handle.net/2108/232698Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85063607028

الإتاحة: https://doi.org/10.3390/ijms20061373Test
http://hdl.handle.net/2108/232698Test

المؤلفون: Annibali O., Piccioni L., Tomarchio V., Circhetta E., Sarlo C., Franceschini L., Cantonetti M., Rizzo E., Angeletti S., Tirindelli M. C., Scagnolari C., Statzu M., Avvisati G., Riva E.

المساهمون: Annibali, O, Piccioni, L, Tomarchio, V, Circhetta, E, Sarlo, C, Franceschini, L, Cantonetti, M, Rizzo, E, Angeletti, S, Tirindelli, Mc, Scagnolari, C, Statzu, M, Avvisati, G, Evstifeeva, R

مصطلحات موضوعية: Adolescent, Adult, Aged, Allele, Cytomegaloviru, Cytomegalovirus Infection, Female, Genotype, Hematopoietic Stem Cell Transplantation, Human, Interferon, Interleukin, Lymphoma, Non-Hodgkin, Male, Middle Aged, Multiple Myeloma, Transplantation, Autologou, Virus Activation, Young Adult, Polymorphism, Single Nucleotide, Settore MED/15 - MALATTIE DEL SANGUE

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30036376; info:eu-repo/semantics/altIdentifier/wos/WOS:000439429200010; volume:13; issue:7; firstpage:e0200221; journal:PLOS ONE; http://hdl.handle.net/2108/242778Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85051755727

الإتاحة: https://doi.org/10.1371/journal.pone.0200221Test
http://hdl.handle.net/2108/242778Test

المؤلفون: Gallamini A., Tarella C., Viviani S., Rossi A., Patti C., Mule A., Picardi M., Romano A., Cantonetti M., Nasa G. L., Trentin L., Bolis S., Rapezzi D., Battistini R., Gottardi D., Gavarotti P., Corradini P., Cimminiello M., Schiavotto C., Parvis G., Zanotti R., Gini G., Ferreri A. J. M., Viero P., Miglino M., Billio A., Avigdor A., Biggi A., Fallanca F., Ficola U., Gregianin M., Chiaravalloti A., Prosperini G., Bergesio F., Chauvie S., Pavoni C., Gianni A. M., Rambaldi A.

المساهمون: Gallamini, A, Tarella, C, Viviani, S, Rossi, A, Patti, C, Mule, A, Picardi, M, Romano, A, Cantonetti, M, Nasa, Gl, Trentin, L, Bolis, S, Rapezzi, D, Battistini, R, Gottardi, D, Gavarotti, P, Corradini, P, Cimminiello, M, Schiavotto, C, Parvis, G, Zanotti, R, Gini, G, Ferreri, Ajm, Viero, P, Miglino, M, Billio, A, Avigdor, A, Biggi, A, Fallanca, F, Ficola, U, Gregianin, M, Chiaravalloti, A, Prosperini, G, Bergesio, F, Chauvie, S, Pavoni, C, Gianni, Am, Rambaldi, A

مصطلحات موضوعية: Adolescent, Adult, Antineoplastic Combined Chemotherapy Protocol, Bleomycin, Cyclophosphamide, Dacarbazine, Doxorubicin, Etoposide, Feasibility Studie, Female, Hodgkin Disease, Human, Lymph Node, Lymphatic Metastasi, Male, Middle Aged, Positron Emission Tomography Computed Tomography, Prednisone, Procarbazine, Prospective Studie, Radiotherapy, Rituximab, Survival Analysi, Vinblastine, Vincristine, Young Adult, Settore MED/15 - MALATTIE DEL SANGUE

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29360414; info:eu-repo/semantics/altIdentifier/wos/WOS:000425027100005; volume:36; issue:5; firstpage:454; lastpage:462; numberofpages:9; journal:JOURNAL OF CLINICAL ONCOLOGY; http://hdl.handle.net/2108/242783Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85041919816

الإتاحة: https://doi.org/10.1200/JCO.2017.75.2543Test
http://hdl.handle.net/2108/242783Test

المؤلفون: Castagnetti, F, Gugliotta, G., Breccia, M., Stagno, F., Iurlo, A., Albano, F., Abruzzese, E., Martino, B., Levato, L., Intermesoli, T., Pregno, P., Rossi, G., Gherlinzoni, F., Leoni, P., Cavazzini, F., Venturi, C., Soverini, S., Testoni, N., Alimena, G., Cavo, M., Martinelli, G., Pane, F., Saglio, G., Rosti, G., Baccarani, M., on behalf of the GIMEMA CML Working Party (Lucarelli, G., Polimeno, G., Ladetto, M., Pini, M., Rupoli, S., Scortechini, A. R., Galieni, P., Bigazzi, C., Cantore, N., Palmieri, F., Specchia, G., Russo, Rossi., Rambaldi, A., Ferrari, M. L., Palandri, F., Luatti, S., Iacobucci, I., Bochicchio, M. T., Apolinari, M., Fogli, M., Cervello, I., Capucci, A., Giuliani, G., Malpignano, A., Girasoli, M., Angelucci, E., Usala, E., De Biasi, E., Tagariello, G., Sartori, R., Di Raimondo, F., Vigneri, P., Molica, S., Lentini, M., Lanza, F., Viganò, C., Grasso, M., Rapezzi, D., Cuneo, A., Ciccone, M., Bosi, A., Gozzini, A., Gobbi, M., Pierri, I., Chianese, R., De Blasio, A., Ciccone, F., Capochiani, E., Pelosini, M., Musolino, C., Russo, S., Cortelezzi, A., Luppi, M., Marasca, R., Pogliani, E. M., Gambacorti-Passerini, C., Luciano, L., Izzo, B., Ferrara, F., Annunziata, M., Mettivier, V., Sessa, U., Latte, G., Noli, D., Rege-Cambrin, G., Fava, C., Semenzato, G., Binotto, G., Fabbiano, F., Turri, D., Siragusa, S., Caracciolo, C., Musso, M., Porretto, F., Cazzola, M., Orlandi, E., Falini, B., Falzetti, F., Visani, G., Isidor, I., Di Bartolomeo, P., Di Lorenzo, R., Vallisa, D., Trabacch, I., Pizzuti, M., Zuffa, E., Salvucci, M., Ronco, F., Lelo, D., Merli, F., Avanzini, P., Tosi, P., Merli, A., Sica, S., Sorà, F., Latagliata, R., De Fabritiis, P., Trawiska, M., Amadori, S., Cantonetti, M., Majolino, I., Pacilli, L., Ronci, B., Cedrone, M., Mengarelli, A., Romano, A., Tafuri, A., Montefusc, O., Iuliano, F., Infusino, S., Dore, F., Fozza, C., Bocchia, M., Defina, M., Liberati, Am., Luzi, D., Boccadoro, M., Ferrero, D., Vitolo, U., Nicolosi, M., Gottardi, M., Calistri, E., Fanin, R., Tiribelli, M., Pizzolo, G., Bonifacio, M., Rodeghiero, F., Di Bona, E. ).

المساهمون: Castagnetti, F, Gugliotta, G., Breccia, M., Stagno, F., Iurlo, A., Albano, F., Abruzzese, E., Martino, B., Levato, L., Intermesoli, T., Pregno, P., Rossi, G., Gherlinzoni, F., Leoni, P., Cavazzini, F., Venturi, C., Soverini, S., Testoni, N., Alimena, G., Cavo, M., Martinelli, G., Pane, F., Saglio, G., Rosti, G., Baccarani, M., and on behalf of the GIMEMA CML Working Party [, Palandri F.], Pane, Fabrizio, Gugliotta, G, Breccia, M, Stagno, F, Iurlo, A, Albano, F, Abruzzese, E, Martino, B, Levato, L, Intermesoli, T, Pregno, P, Rossi, G, Gherlinzoni, F, Leoni, P, Cavazzini, F, Venturi, C, Soverini, S, Testoni, N, Alimena, G, Cavo, M, Martinelli, G, Pane, F, Saglio, G, Rosti, G, Baccarani, M, GAMBACORTI PASSERINI, C

مصطلحات موضوعية: DIAGNOSED CHRONIC-PHASE, Oncology, Male, Cancer Research, Time Factors, bcr-abl, Fusion Proteins, bcr-abl, Antineoplastic Agent, Hematology, Anesthesiology and Pain Medicine, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Cumulative incidence, Young adult, Chronic, Aged, 80 and over, Leukemia, PATIENTS RECEIVING IMATINIB, CHRONIC MYELOGENOUS LEUKEMIA, TYROSINE KINASE INHIBITORS, BCR-ABL1 TRANSCRIPT LEVELS, EARLY MOLECULAR RESPONSE, CML WORKING PARTY, 3-YEAR FOLLOW-UP, EUROPEAN LEUKEMIANET, 400 MG, Myeloid leukemia, Middle Aged, Prognosis, Treatment Outcome, Retreatment, Imatinib Mesylate, Female, Tyrosine kinase, Human, medicine.drug, Adult, medicine.medical_specialty, Time Factor, Adolescent, Prognosi, Protein Kinase Inhibitor, Socio-culturale, Antineoplastic Agents, Treatment results, Follow-Up Studie, Young Adult, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Internal medicine, medicine, Humans, Protein Kinase Inhibitors, Aged, Antineoplastic Combined Chemotherapy Protocol, business.industry, Fusion Proteins, Imatinib, Follow-Up Studies, Surgery, Imatinib mesylate, BCR-ABL Positive, business, Myelogenous

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9a3f6a783375013273256c71341e1c8Test
http://hdl.handle.net/11365/1002418Test

المؤلفون: Zinzani, P. L., Martelli, M., Magagnoli, M., Zaccaria, A., Ronconi, F., Cantonetti, M., Bocchia, M., Marra, R., Gobbi, M., Brunangelo FALINI, Gherlinzoni, F., Moretti, L., Renzo, A., Mazza, P., Pavone, E., Sabattini, E., Amendola, A., Bendandi, M., Pileri, S. A., Mandelli, F., Tura, S.

المصدر: Scopus-Elsevier

مصطلحات موضوعية: Male, Lymphoma, Settore MED/06 - Oncologia Medica, Leucovorin, vincristine EMTREE medical terms: adult, Antineoplastic Combined Chemotherapy Protocols, anaplastic carcinoma, Tomography, Ki-1, clinical article, large cell lymphoma, Remission Induction, article, Mediastinum, clinical trial, Middle Aged, Combined Modality Therapy, Hodgkin Disease, Large-Cell, Dacarbazine, aged, female, Treatment Outcome, priority journal, Vincristine, Lymphoma, Large-Cell, Anaplastic, EMTREE drug terms:bleomycin, cyclophosphamide, dacarbazine, doxorubicin, folinic acid, methotrexate, prednisone, vinblastine, antineoplastic activity, cancer combination chemotherapy, cancer radiotherapy, controlled study, human, human tissue, male, randomized controlled trial, treatment outcome MeSH:Adolescent, Adult, Bleomycin, Cyclophosphamide, Disease-Free Survival, Doxorubicin, Female, Follow-Up Studies, Humans, Lymphoma, Large-Cell, Ki-1, Methotrexate, Prednisone, Survival Analysis, Tomography, Emission-Computed, Single-Photon, Vinblastine, Adolescent, adult, cd30+/ki-1+, classification, clinical-features, disease, f-machop regimen, reed-sternberg cells, variant, Emission-Computed, Settore MED/15 - Malattie del Sangue, Single-Photon

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::987c2cd269fcebdb18f4ec29055b6c66Test
http://www.scopus.com/inward/record.url?eid=2-s2.0-0032147217&partnerID=MN8TOARSTest

المؤلفون: Tribalto, M., Cantonetti, M., Catalano, G., GIOVANNI DEL POETA, Masi, M., Pastore, S., Pisani, F., Stasi, R., Papa, G.

المصدر: Europe PubMed Central
Scopus-Elsevier

مصطلحات موضوعية: Risk, EMTREE drug terms: cytarabine, Settore MED/06 - Oncologia Medica, mitoxantrone EMTREE medical terms: acute nonlymphocytic leukemia, Acute, etoposide, Middle Age, male, Antineoplastic Combined Chemotherapy Protocols, Humans, controlled study, human, clinical article, Leukemia, adult, human cell, Remission Induction, article, Cytarabine, Middle Aged, adolescent, aged, female, prognosis, subcutaneous drug administration MeSH: Antineoplastic Combined Chemotherapy Protocols, Drug Evaluation, Etoposide, Human, Leukemia, Nonlymphocytic, Acute, Mitoxantrone, Prognosis, Survival Rate, Leukemia, Myeloid, Acute, Nonlymphocytic, Settore MED/15 - Malattie del Sangue

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::68c305cae70e34053e1d9cfbd4c3f12fTest
http://europepmc.org/abstract/med/1806445Test

المؤلفون: Federico Fallanca, Roberto Sorasio, Umberto Ficola, Silvia Bolis, Guido Gini, Simonetta Viviani, Alessandra Romano, Piera Viero, Roberta Zanotti, Michele Cimminiello, Luca Guerra, Sara Oppi, Andrea Gallamini, Alessandro Rambaldi, Caterina Patti, Marco Picardi, Roberta Battistini, Livio Trentin, Andrea Rossi, Corrado Tarella, Corrado Schiavotto, Antonino Mulè, Maria Cantonetti, Chiara Pavoni, Stephane Chauvie

المساهمون: Gallamini, Andrea, Rossi, Andrea, Patti, Caterina, Picardi, Marco, Romano, Alessandra, Cantonetti, Maria, Oppi, Sara, Viviani, Simonetta, Bolis, Silvia, Trentin, Livio, Gini, Guido, Battistini, Roberta, Chauvie, Stephane, Sorasio, Roberto, Pavoni, Chiara, Zanotti, Roberta, Cimminiello, Michele, Schiavotto, Corrado, Viero, Piera, Mulé, Antonino, Fallanca, Federico, Ficola, Umberto, Tarella, Corrado, Guerra, Luca, Rambaldi, Alessandro, Gallamini, A, Rossi, A, Patti, C, Picardi, M, Romano, A, Cantonetti, M, Oppi, S, Viviani, S, Bolis, S, Trentin, L, Gini, G, Battistini, R, Chauvie, S, Sorasio, R, Pavoni, C, Zanotti, R, Cimminiello, M, Schiavotto, C, Viero, P, Mulé, A, Fallanca, F, Ficola, U, Tarella, C, Guerra, L, Rambaldi, A

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Adolescent, Lymphoma, medicine.medical_treatment, Kaplan-Meier Estimate, Vinblastine, law.invention, Bleomycin, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Prospective Studies, Progression-free survival, Young adult, Prospective cohort study, radiotherapy, Neoplasm Staging, business.industry, hodgkin lymphoma, Middle Aged, medicine.disease, Hodgkin Disease, Progression-Free Survival, Dacarbazine, Radiation therapy, Oncology, ABVD, Doxorubicin, 030220 oncology & carcinogenesis, Hodgkin lymphoma, Female, Lymph Nodes, Radiology, business, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::455b594f83198e89f5d69cd3f44bc4d0Test
http://hdl.handle.net/11588/823892Test

المؤلفون: Maria Cantonetti, Emilio Berti, Mario Busetto, Richard W. Tsang, Andreas H. Sarris, Emanuele Zucca, Graziella Pinotti, Marina Frontani, Andrés J.M. Ferreri, Enrico Pogliani, Michael Mian, Andrea Rossi, Liliana Devizzi, Giovanni Martinelli, Stefano Luminari, Massimo Federico, Alessandro Rambaldi, Luigi Marcheselli, Alessandro Massimo Gianni, Sergio Cortelazzo

المساهمون: Department of Hematology, Azienda Ospedaliera S. Maurizio, Hospital of Bolzano, Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Department of Oncology and Hematology, Università degli Studi di Modena e Reggio Emilia (UNIMORE), Università degli Studi di Roma Tor Vergata [Roma], Hygeia Hospital and Harvard Medical International, Division of Hematology, Ospedali Riuniti, III Division of Dermatology, Istituto dermopatico dell'immacolata (IDI-IRCCS), Medical Oncology 3 and Bone Marrow Transplantation Unit, Fondazione Istituto Nazionale per lo Studio e la Cura dei Tumori, University of Milan, Department of Radiotherapy, Sezione Oncoematologica, Università degli Studi di Milano-Bicocca [Milano] (UNIMIB), Division of Haematology, European Institute of Oncology [Milan] (ESMO), Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, Unit of Lymphoid Malignancies, San Raffaele Scientific Institute, Oncology, Oncology Institute of Southern Switzerland, Mian, M, Marcheselli, L, Luminari, S, Federico, M, Cantonetti, M, Sarris, A, Rossi, A, Rambaldi, A, Frontani, M, Devizzi, L, Gianni, A, Busetto, M, Berti, E, Martinelli, G, Tsang, R, Ferreri, A, Pinotti, G, Pogliani, E, Zucca, E, Cortelazzo, S

المصدر: Annals of Hematology
Annals of Hematology, Springer Verlag, 2010, 90 (4), pp.401-408. ⟨10.1007/s00277-010-1083-1⟩

مصطلحات موضوعية: Male, Oncology, Skin Neoplasms, Lymphoma, B-cell, Kaplan-Meier Estimate, 01 natural sciences, 010104 statistics & probability, CLIPI, 0302 clinical medicine, MED/15 - MALATTIE DEL SANGUE, Stage (cooking), Young adult, Aged, 80 and over, B cell, Hematology, General Medicine, Middle Aged, Prognosis, 3. Good health, Cutaneou, Survival Rate, 030220 oncology & carcinogenesis, cutaneos, Female, Adult, medicine.medical_specialty, Lymphoma, B-Cell, lymphoma, prognostic index, Adolescent, Cutaneous B-cell lymphoma, Prognostic index, Disease-Free Survival, Young Adult, 03 medical and health sciences, Internal medicine, medicine, Humans, 0101 mathematics, Survival rate, Aged, Proportional Hazards Models, Retrospective Studies, Proportional hazards model, business.industry, Retrospective cohort study, medicine.disease, Surgery, Cutaneous, business, Settore MED/15 - Malattie del Sangue

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23ff55be632779d6b145056140567955Test
https://hdl.handle.net/11380/645108Test